
<http://bio2rdf.org/drugbank:DB00012> a <http://schema.org/Drug> ;
	<http://schema.org/name> "Darbepoetin alfa" ;
	<http://schema.org/description> "Human erythropoietin with 2 aa substitutions to enhance glycosylation (5 N-linked chains), 165 residues (MW=37 kD). Produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology." ;
	<http://schema.org/drugClass> "Anti-anemic Agents" , "Hematinics" ;
	<http://schema.org/url> "https://schemaorg.metadatacenter.org/drugbank/DB00012.html" ;
	<http://schema.org/administrationRoute> "intravenous; subcutaneous" ;
	<http://schema.org/availableStrength> <http://bio2rdf.org/drugbank_resource:a29b6ff1d9621f5627109571f3320f96> , <http://bio2rdf.org/drugbank_resource:f44438f1d684894d9637635bf79481fa> , <http://bio2rdf.org/drugbank_resource:236fe4520481468a4bc545c6ed3415c8> , <http://bio2rdf.org/drugbank_resource:e611777dcd00eb005a928f054e59aaac> , <http://bio2rdf.org/drugbank_resource:173bde59b99dc80c4620936bc6422672> , <http://bio2rdf.org/drugbank_resource:c2eef74d6d7831d7fac384b8f29c6b93> , <http://bio2rdf.org/drugbank_resource:c1c5c1f6415fb6803cce1f15b1e189f4> , <http://bio2rdf.org/drugbank_resource:fcbf33e125f2178340b509f9fc553eb6> , <http://bio2rdf.org/drugbank_resource:df4b03f79c8fc59dd39cb124e9b027d2> , <http://bio2rdf.org/drugbank_resource:4c2818f5777eed65766f24fed90889ac> , <http://bio2rdf.org/drugbank_resource:5a1915022b533b922ef23d0a124782de> , <http://bio2rdf.org/drugbank_resource:bc5c563aa4fb7631198aa3f3c994a10f> , <http://bio2rdf.org/drugbank_resource:ec5f04a535f115c17b6090d5ba5b1d58> , <http://bio2rdf.org/drugbank_resource:6fbfbfff388fd379832e781808aff709> , <http://bio2rdf.org/drugbank_resource:05261f01381fee213654fb0aa730154d> ;
	<http://schema.org/clinicalPharmacology> "Darbepoetin alfa is used in the treatment of anemia. It is involved in the regulation of erythrocyte differentiation and the maintenance of a physiological level of circulating erythrocyte mass." ;
	<http://schema.org/cost> <http://bio2rdf.org/drugbank_resource:6d74ab91151915286d693c242718551e> , <http://bio2rdf.org/drugbank_resource:e6a7bed654c08462f1080b955bf6da79> , <http://bio2rdf.org/drugbank_resource:41c5253c6154e548c11b3e1c16769d60> , <http://bio2rdf.org/drugbank_resource:e0d7e969866c0b3e8367129c848cec19> , <http://bio2rdf.org/drugbank_resource:62ee293ada9dc15e66997f4e370269ae> , <http://bio2rdf.org/drugbank_resource:012451b140df29be7829f0a893b8fdd5> , <http://bio2rdf.org/drugbank_resource:ffcd199ae76cd840e9955ed25196dbbd> , <http://bio2rdf.org/drugbank_resource:2e0c27d2010c25dc42cca3bb185e4caa> , <http://bio2rdf.org/drugbank_resource:cced8854da43c42f9334b90870928736> , <http://bio2rdf.org/drugbank_resource:ab1b17bf936f0716312e2ea99ea950d0> , <http://bio2rdf.org/drugbank_resource:8e0efd1644c41a8be5a3ff2b5eb42309> , <http://bio2rdf.org/drugbank_resource:469766f35e2df5b8707af6247376d360> ;
	<http://schema.org/dosageForm> "Solution" , "Injection, solution" ;
	<http://schema.org/interactingDrug> "DDI between Darbepoetin alfa and Lenalidomide - Erythropoiesis-Stimulating Agents may enhance the thrombogenic effect of Lenalidomide." , "DDI between Darbepoetin alfa and Thalidomide - Erythropoiesis-Stimulating Agents may enhance the thrombogenic effect of Thalidomide." ;
	<http://schema.org/legalStatus> "Investigational" , "Approved" ;
	<http://schema.org/manufacturer> <http://bio2rdf.org/drugbank_resource:57ece33d2257828c2085d6236cee7198> ;
	<http://schema.org/mechanismOfAction> """Darbepoetin alfa stimulates erythropoiesis by the same mechanism as endogenous erythropoietin. Erythropoietin interacts with
progenitor stem cells to increase red cell production. Binding of erythropoietin to the erythropoietin receptor leads to receptor dimerization, which facilitates activation of JAK-STAT signaling pathways within the cytosol. Activated STAT (signal transducers and activators of transcription) proteins are then translocated to the nucleus where they serve as transcription factors which regulate the activation of specific genes involved in cell division or differentiation.""" ;
	<http://schema.org/nonProprietaryName> "Epoetin" , "Erythropoietin precursor" ;
	<http://schema.org/identifier> "drugbank:DB00012" ;
	<http://schema.org/sameAs> <http://www.drugs.com/cdi/darbepoetin-alfa-albumin.html> , <http://www.drugbank.ca/drugs/DB00012> , <http://www.rxlist.com/cgi/generic/aranesp.htm> .

<http://bio2rdf.org/drugbank_resource:012451b140df29be7829f0a893b8fdd5> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "1876.3199462890625" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Aranesp 300 mcg/ml vial" .

<http://bio2rdf.org/drugbank_resource:05261f01381fee213654fb0aa730154d> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "150 ug/.3mL Injection, solution form with intravenous; subcutaneous route" .

<http://bio2rdf.org/drugbank_resource:173bde59b99dc80c4620936bc6422672> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "100 ug/mL Solution form with intravenous; subcutaneous route" .

<http://bio2rdf.org/drugbank_resource:236fe4520481468a4bc545c6ed3415c8> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "200 ug/mL Solution form with intravenous; subcutaneous route" .

<http://bio2rdf.org/drugbank_resource:2e0c27d2010c25dc42cca3bb185e4caa> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "2601.830078125" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Aranesp (Albumin Free) 100 mcg/ml Solution Four 1ml Vials Per Box" .

<http://bio2rdf.org/drugbank_resource:41c5253c6154e548c11b3e1c16769d60> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "162.6100006103515625" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Aranesp (Albumin Free) 25 mcg/ml vial" .

<http://bio2rdf.org/drugbank_resource:469766f35e2df5b8707af6247376d360> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "1250.8800048828125" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Aranesp 200 mcg/ml vial" .

<http://bio2rdf.org/drugbank_resource:4c2818f5777eed65766f24fed90889ac> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "25 ug/.42mL Injection, solution form with intravenous; subcutaneous route" .

<http://bio2rdf.org/drugbank_resource:57ece33d2257828c2085d6236cee7198> a <http://schema.org/Organization> ;
	<http://schema.org/name> "Amgen Inc." .

<http://bio2rdf.org/drugbank_resource:5a1915022b533b922ef23d0a124782de> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "40 ug/mL Solution form with intravenous; subcutaneous route" .

<http://bio2rdf.org/drugbank_resource:62ee293ada9dc15e66997f4e370269ae> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "250.1999969482421875" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Aranesp 40 mcg/ml vial" .

<http://bio2rdf.org/drugbank_resource:6d74ab91151915286d693c242718551e> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "390.30999755859375" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Aranesp (Albumin Free) 60 mcg/ml vial" .

<http://bio2rdf.org/drugbank_resource:6fbfbfff388fd379832e781808aff709> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "300 ug/.6mL Injection, solution form with intravenous; subcutaneous route" .

<http://bio2rdf.org/drugbank_resource:8e0efd1644c41a8be5a3ff2b5eb42309> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "1951.3699951171875" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Aranesp (Albumin Free) 300 mcg/ml vial" .

<http://bio2rdf.org/drugbank_resource:a29b6ff1d9621f5627109571f3320f96> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "150 ug/.75mL Solution form with intravenous; subcutaneous route" .

<http://bio2rdf.org/drugbank_resource:ab1b17bf936f0716312e2ea99ea950d0> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "3902.75" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Aranesp (Albumin Free) 150 mcg/0.75ml Solution (1 Box = Four 0.75ml Vials)" .

<http://bio2rdf.org/drugbank_resource:bc5c563aa4fb7631198aa3f3c994a10f> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "500 ug/mL Injection, solution form with intravenous; subcutaneous route" .

<http://bio2rdf.org/drugbank_resource:c1c5c1f6415fb6803cce1f15b1e189f4> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "60 ug/.3mL Injection, solution form with intravenous; subcutaneous route" .

<http://bio2rdf.org/drugbank_resource:c2eef74d6d7831d7fac384b8f29c6b93> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "100 ug/.5mL Injection, solution form with intravenous; subcutaneous route" .

<http://bio2rdf.org/drugbank_resource:cced8854da43c42f9334b90870928736> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "375.29998779296875" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Aranesp 60 mcg/ml vial" .

<http://bio2rdf.org/drugbank_resource:df4b03f79c8fc59dd39cb124e9b027d2> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "25 ug/mL Solution form with intravenous; subcutaneous route" .

<http://bio2rdf.org/drugbank_resource:e0d7e969866c0b3e8367129c848cec19> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "625.44000244140625" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Aranesp 100 mcg/ml vial" .

<http://bio2rdf.org/drugbank_resource:e611777dcd00eb005a928f054e59aaac> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "60 ug/mL Solution form with intravenous; subcutaneous route" .

<http://bio2rdf.org/drugbank_resource:e6a7bed654c08462f1080b955bf6da79> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "156.3600006103515625" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Aranesp 25 mcg/ml vial" .

<http://bio2rdf.org/drugbank_resource:ec5f04a535f115c17b6090d5ba5b1d58> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "200 ug/.4mL Injection, solution form with intravenous; subcutaneous route" .

<http://bio2rdf.org/drugbank_resource:f44438f1d684894d9637635bf79481fa> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "300 ug/mL Solution form with intravenous; subcutaneous route" .

<http://bio2rdf.org/drugbank_resource:fcbf33e125f2178340b509f9fc553eb6> a <http://schema.org/DrugStrength> ;
	<http://schema.org/description> "40 ug/.4mL Injection, solution form with intravenous; subcutaneous route" .

<http://bio2rdf.org/drugbank_resource:ffcd199ae76cd840e9955ed25196dbbd> a <http://schema.org/DrugCost> ;
	<http://schema.org/costPerUnit> "2601.830078125" ;
	<http://schema.org/costCurrency> "USD" ;
	<http://schema.org/drugUnit> "Aranesp (Albumin Free) 100 mcg/0.5ml Solution (1 Box = Four 0.5ml Syringes)" .
